Alps Advisors Inc Alector, Inc. Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Alector, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 77,232 shares of ALEC stock, worth $314,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,232
Previous 75,177 2.73%
Holding current value
$314,334
Previous $341,000 5.57%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$4.34 - $6.58 $8,918 - $13,521
2,055 Added 2.73%
77,232 $360,000
Q2 2024

Aug 13, 2024
BUY
$4.19 - $6.23 $32,036 - $47,634
7,646 Added 11.32%
75,177 $341,000
Q1 2024

May 14, 2024
BUY
$5.69 - $8.08 $61,116 - $86,787
10,741 Added 18.91%
67,531 $406,000
Q4 2023

Feb 14, 2024
SELL
$3.77 - $8.39 $19,008 - $42,302
-5,042 Reduced 8.15%
56,790 $453,000
Q3 2023

Nov 14, 2023
BUY
$5.2 - $8.77 $2,922 - $4,928
562 Added 0.92%
61,832 $400,000
Q2 2023

Aug 14, 2023
BUY
$5.86 - $7.93 $38,476 - $52,068
6,566 Added 12.0%
61,270 $368,000
Q1 2023

May 10, 2023
SELL
$5.85 - $9.84 $7,926 - $13,333
-1,355 Reduced 2.42%
54,704 $338,000
Q4 2022

Feb 14, 2023
BUY
$6.88 - $9.55 $75,707 - $105,088
11,004 Added 24.42%
56,059 $517,000
Q3 2022

Nov 14, 2022
SELL
$8.19 - $13.2 $31,007 - $49,975
-3,786 Reduced 7.75%
45,055 $426,000
Q2 2022

Aug 11, 2022
SELL
$7.65 - $14.24 $270,993 - $504,437
-35,424 Reduced 42.04%
48,841 $496,000
Q1 2022

May 16, 2022
SELL
$13.02 - $20.78 $127,478 - $203,456
-9,791 Reduced 10.41%
84,265 $1.2 Million
Q4 2021

Feb 09, 2022
SELL
$19.35 - $25.54 $98,123 - $129,513
-5,071 Reduced 5.12%
94,056 $1.94 Million
Q3 2021

Nov 15, 2021
SELL
$21.65 - $39.49 $111,107 - $202,662
-5,132 Reduced 4.92%
99,127 $2.26 Million
Q2 2021

Aug 11, 2021
SELL
$15.5 - $22.48 $606,205 - $879,192
-39,110 Reduced 27.28%
104,259 $2.17 Million
Q1 2021

May 07, 2021
BUY
$14.84 - $22.23 $1,498 - $2,245
101 Added 0.07%
143,369 $2.89 Million
Q4 2020

Feb 03, 2021
BUY
$9.4 - $16.7 $396,548 - $704,506
42,186 Added 41.73%
143,268 $2.17 Million
Q3 2020

Nov 04, 2020
SELL
$10.54 - $24.96 $70,870 - $167,831
-6,724 Reduced 6.24%
101,082 $1.07 Million
Q2 2020

Aug 05, 2020
SELL
$21.87 - $33.11 $706,554 - $1.07 Million
-32,307 Reduced 23.06%
107,806 $2.64 Million
Q1 2020

May 06, 2020
BUY
$16.25 - $35.28 $19,418 - $42,159
1,195 Added 0.86%
140,113 $3.38 Million
Q4 2019

Feb 07, 2020
BUY
$14.17 - $20.3 $1.97 Million - $2.82 Million
138,918 New
138,918 $2.39 Million

Others Institutions Holding ALEC

# of Institutions
167
Shares Held
57.8M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $336M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email